(Q34300880)

1 August 2017

title

Soluble ST2 in ambulatory patients with heart failure: Association with functional capacity and long-term outcomes (English)

1 reference

1 August 2017

0 references

12

Faiez Zannad

1 reference

1 August 2017

Christopher M O'Connor

14

object named as

Christopher M O'Connor

1 reference

1 August 2017

13

William E Kraus

1 reference

1 August 2017

1

G Michael Felker

1 reference

1 August 2017

11

Ileana L Piña

1 reference

1 August 2017

6

Kirkwood F Adams

1 reference

1 August 2017

7

David J Whellan

1 reference

1 August 2017

10

Dalane W Kitzman

1 reference

1 August 2017

5

Megan L Neely

1 reference

1 August 2017

Mona Fiuzat

2

1 reference

1 August 2017

Vivian Thompson

3

1 reference

1 August 2017

Linda K Shaw

4

1 reference

1 August 2017

Mark P Donahue

8

1 reference

1 August 2017

Tariq Ahmad

9

1 reference

1 August 2017

publication date

8 October 2013

1 reference

Circulation: Heart Failure

1 August 2017

published in

1 reference

1 August 2017

volume

6

1 reference

1 August 2017

issue

6

1 reference

1 August 2017

page(s)

1172-1179

1 reference

Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188425

Heart disease and stroke statistics--2012 update: a report from the American Heart Association

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188425

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188425

Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188425

Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188425

The IL-33/ST2 pathway--A new therapeutic target in cardiovascular disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188425

High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188425

Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188425

Serum soluble ST2: a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188425

Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188425

Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188425

Biomarkers in heart failure

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188425

Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188425

Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188425

IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188425

Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188425

Identification of serum soluble ST2 receptor as a novel heart failure biomarker

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188425

Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188425

Establishment of reference intervals for soluble ST2 from a United States population.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188425

Heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION): design and rationale

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188425

Extracellular Matrix Turnover and Inflammatory Markers Independently Predict Functional Status and Outcome in Chronic Heart Failure

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188425

Trends in Heart Failure Incidence and Survival in a Community-Based Population

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188425

Interleukin-33 prevents apoptosis and improves survival after experimental myocardial infarction through ST2 signaling

28 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24103327

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Relationship between physical activity and inflammation among apparently healthy middle-aged and older US adults

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24103327

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1161/CIRCHEARTFAILURE.113.000207

1 reference

1 August 2017

1 reference

1 August 2017

1 reference